title: Genetics of multiple myeloma: another heterogeneity level?
abstract: Our knowledge of myeloma genetics remained limited and lagged behind many other hematologic malignancies because of the inherent difficulties in generating metaphases within the malignant plasma cell clone. With the development of molecular techniques (microarrays and next-generation sequencing), our understanding has been highly improved in the past 5 years. These studies have not only confirmed the prevalence of wide heterogeneity in myeloma at the molecular level, but has also provided a much clearer picture of the disease pathogenesis and progression. Whether these data will enable improvements in the therapeutic approach is still a matter of debate. The next improvement will come from detailed analyses of these molecular features to try to move from a treatment fitted to every patient to individualized therapies, taking into account the complexity of the chromosomal changes, the mutation spectrum, and subclonality evolution.
authors: Unit for Genomics in Myeloma, L'Institut Universitaire du Cancer de Toulouse-Oncopole, Centre Hospitalier Universitaire, Toulouse, France; Centre de Recherche en Cancérologie de Toulouse Institut National de la Santé et de la Recherche Médicale U1037, Toulouse, France;
authors: Jill
authors: J
authors: Corre
authors: Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and Boston Veterans Administration Healthcare System, West Roxbury, MA.
authors: Nikhil
authors: N
authors: Munshi
authors: Unit for Genomics in Myeloma, L'Institut Universitaire du Cancer de Toulouse-Oncopole, Centre Hospitalier Universitaire, Toulouse, France; Centre de Recherche en Cancérologie de Toulouse Institut National de la Santé et de la Recherche Médicale U1037, Toulouse, France;
authors: Hervé
authors: H
authors: Avet-Loiseau
mesh_terms: D000368:Aged; D001402:B-Lymphocytes / Q000166:cytology; D063646:Carcinogenesis; D002454:Cell Differentiation; D002471:Cell Transformation, Neoplastic; D004252:DNA Mutational Analysis; D018450:Disease Progression; D006801:Humans; D008954:Models, Biological; D009101:Multiple Myeloma / Q000175:diagnosis* / Q000235:genetics* / Q000503:physiopathology; D009154:Mutation; D020411:Oligonucleotide Array Sequence Analysis; D010950:Plasma Cells / Q000473:pathology; D020641:Polymorphism, Single Nucleotide; D011379:Prognosis
references: Haematologica. 2010 Nov;95(11):1973-6
references: 20634494
references: Blood. 2010 Oct 7;116(14):2543-53
references: 20574050
references: Nature. 2011 Mar 24;471(7339):467-72
references: 21430775
references: N Engl J Med. 2011 Jun 16;364(24):2305-15
references: 21663470
references: J Clin Oncol. 2012 Jun 1;30(16):1949-52
references: 22547600
references: Blood. 2012 Aug 2;120(5):1067-76
references: 22498740
references: Blood. 2012 Aug 2;120(5):1060-6
references: 22529291
references: N Engl J Med. 2012 Aug 30;367(9):826-33
references: 22931316
references: Leukemia. 2013 Feb;27(2):473-81
references: 22874878
references: Blood. 2013 Mar 28;121(13):2415-23
references: 23321258
references: Clin Cancer Res. 2013 Sep 1;19(17):4634-7
references: 23857603
references: Blood. 2003 Feb 15;101(4):1520-9
references: 12393535
references: Blood. 2003 Mar 15;101(6):2374-6
references: 12433679
references: Blood. 2003 Jun 1;101(11):4569-75
references: 12576322
references: Blood. 2003 Oct 1;102(7):2562-7
references: 12805059
references: Cancer Cell. 2004 Feb;5(2):191-9
references: 14998494
references: Br J Haematol. 2004 Apr;125(1):64-8
references: 15015970
references: Blood. 1985 Aug;66(2):380-90
references: 3926026
references: Blood. 1995 May 1;85(9):2490-7
references: 7537117
references: Cancer Genet Cytogenet. 1995 Jul 1;82(1):41-9
references: 7627933
references: Blood. 1996 Jul 15;88(2):674-81
references: 8695815
references: Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13931-6
references: 8943038
references: Genes Chromosomes Cancer. 1997 Feb;18(2):84-93
references: 9115968
references: Nat Genet. 1997 Jul;16(3):260-4
references: 9207791
references: Cancer Discov. 2013 Aug;3(8):862-9
references: 23612012
references: Blood. 2013 Apr 25;121(17):3413-9
references: 23435460
references: Nat Commun. 2014;5:2997
references: 24429703
references: Cancer Cell. 2014 Jan 13;25(1):91-101
references: 24434212
references: Leukemia. 2014 Mar;28(3):675-9
references: 23892719
references: Leukemia. 2014 Aug;28(8):1725-35
references: 24518206
references: Leukemia. 2014 Nov;28(11):2229-34
references: 24732597
references: Blood. 2014 Nov 13;124(20):3110-7
references: 25237203
references: Blood. 2015 Mar 26;125(13):2095-100
references: 25636340
references: Blood. 2006 Sep 1;108(5):1733-43
references: 16705090
references: Nature. 2000 Feb 3;403(6769):503-11
references: 10676951
references: Jpn J Cancer Res. 2001 Jun;92(6):638-44
references: 11429052
references: Blood. 2001 Oct 1;98(7):2229-38
references: 11568011
references: Blood. 2002 Mar 1;99(5):1745-57
references: 11861292
references: Blood. 1997 Jul 15;90(2):526-34
references: 9226151
references: Blood. 1998 Jun 15;91(12):4457-63
references: 9616139
references: Blood. 1998 Nov 1;92(9):3025-34
references: 9787135
references: Cancer Res. 1998 Dec 15;58(24):5640-5
references: 9865713
references: Blood. 2005 Jul 1;106(1):296-303
references: 15755896
references: Blood. 2005 Aug 15;106(4):1164-74
references: 15855278
references: J Clin Oncol. 2005 Sep 10;23(26):6333-8
references: 16155016
references: Blood. 2005 Oct 15;106(8):2837-40
references: 15976175
references: Hematology Am Soc Hematol Educ Program. 2005;:346-52
references: 16304402
references: Cancer Cell. 2006 Apr;9(4):313-25
references: 16616336
references: Blood. 2006 Sep 1;108(5):1724-32
references: 16705089
references: Blood. 2006 Sep 15;108(6):2020-8
references: 16728703
references: Leukemia. 2006 Nov;20(11):2034-40
references: 17024118
references: Leukemia. 2007 Jan;21(1):143-50
references: 17024116
references: Blood. 2007 Apr 15;109(8):3489-95
references: 17209057
references: Cancer Cell. 2007 Aug;12(2):115-30
references: 17692804
references: Cancer Cell. 2007 Aug;12(2):131-44
references: 17692805
references: Leukemia. 2007 Sep;21(9):2020-4
references: 17625611
references: J Clin Oncol. 2008 Oct 10;26(29):4798-805
references: 18591550
references: Blood. 2009 Mar 5;113(10):2290-7
references: 19050310
references: Blood. 2009 May 28;113(22):5412-7
references: 19179464
references: Blood. 2009 May 28;113(22):5418-22
references: 19234139
references: J Clin Oncol. 2009 Sep 20;27(27):4585-90
references: 19687334
references: Blood. 2011 Jan 6;117(1):211-20
references: 20974671